These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion. Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700 [TBL] [Abstract][Full Text] [Related]
3. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway. Zhang H; Sun JD; Yan LJ; Zhao XP Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. Ogunwobi OO; Liu C Clin Exp Metastasis; 2011 Dec; 28(8):721-31. PubMed ID: 21744257 [TBL] [Abstract][Full Text] [Related]
5. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR. Li L; Zhang S; Li H; Chou H BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201 [TBL] [Abstract][Full Text] [Related]
6. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949 [TBL] [Abstract][Full Text] [Related]
9. CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma. Lv B; Yang X; Lv S; Wang L; Fan K; Shi R; Wang F; Song H; Ma X; Tan X; Xu K; Xie J; Wang G; Feng M; Zhang L Mol Neurobiol; 2015 Dec; 52(3):1263-1268. PubMed ID: 25326893 [TBL] [Abstract][Full Text] [Related]
10. Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy. Thomson S; Petti F; Sujka-Kwok I; Epstein D; Haley JD Clin Exp Metastasis; 2008; 25(8):843-54. PubMed ID: 18696232 [TBL] [Abstract][Full Text] [Related]
11. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells. Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631 [TBL] [Abstract][Full Text] [Related]
13. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways. Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956 [TBL] [Abstract][Full Text] [Related]
14. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling. Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214 [TBL] [Abstract][Full Text] [Related]
15. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway. Cheng Z; Guo Y; Yang Y; Kan J; Dai S; Helian M; Li B; Xu J; Liu C Oncol Rep; 2016 Aug; 36(2):1023-9. PubMed ID: 27279040 [TBL] [Abstract][Full Text] [Related]
16. ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program. Dang TT; Esparza MA; Maine EA; Westcott JM; Pearson GW Cancer Res; 2015 Sep; 75(18):3925-35. PubMed ID: 26292362 [TBL] [Abstract][Full Text] [Related]
17. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221 [TBL] [Abstract][Full Text] [Related]
18. Slug/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma. Idoux-Gillet Y; Nassour M; Lakis E; Bonini F; Theillet C; Du Manoir S; Savagner P Oncogene; 2018 Feb; 37(5):578-588. PubMed ID: 28991231 [TBL] [Abstract][Full Text] [Related]
19. FGF signalling through RAS/MAPK and PI3K pathways regulates cell movement and gene expression in the chicken primitive streak without affecting E-cadherin expression. Hardy KM; Yatskievych TA; Konieczka J; Bobbs AS; Antin PB BMC Dev Biol; 2011 Mar; 11():20. PubMed ID: 21418646 [TBL] [Abstract][Full Text] [Related]
20. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis. Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]